Schmidt Marcel, Toplak Ana, Quaedflieg Peter J L M, van Maarseveen Jan H, Nuijens Timo
EnzyPep B.V., Brightlands Campus, Urmonderbaan 22, 6167 RD Geleen, The Netherlands; Van 't Hoff Institute for Molecular Sciences, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, The Netherlands.
EnzyPep B.V., Brightlands Campus, Urmonderbaan 22, 6167 RD Geleen, The Netherlands.
Drug Discov Today Technol. 2017 Dec;26:11-16. doi: 10.1016/j.ddtec.2017.11.007. Epub 2017 Nov 26.
The recent advancement of peptide macrocycles as promising therapeutics creates a need for novel methodologies for their efficient synthesis and (large scale) production. Within this context, due to the favorable properties of biocatalysts, enzyme-mediated methodologies have gained great interest. Enzymes such as sortase A, butelase 1, peptiligase and omniligase-1 represent extremely powerful and valuable enzymatic tools for peptide ligation, since they can be applied to generate complex cyclic peptides with exquisite biological activity. Therefore, the use of enzymatic strategies will effectively supplement the scope of existing chemical methodologies and will accelerate the development of future cyclic peptide therapeutics. The advantages and disadvantages of the different enzymatic methodologies will be discussed in this review.
作为有前景的治疗药物,肽大环化合物的最新进展引发了对其高效合成和(大规模)生产新方法的需求。在此背景下,由于生物催化剂具有良好的特性,酶介导的方法引起了极大的关注。诸如分选酶A、布特酶1、肽连接酶和全连接酶-1等酶是用于肽连接的极其强大且有价值的酶工具,因为它们可用于生成具有出色生物活性的复杂环肽。因此,酶促策略的使用将有效地补充现有化学方法的范围,并将加速未来环肽治疗药物的开发。本文将讨论不同酶促方法的优缺点。